According to newly uncovered Pfizer documents that came from the FDA’s release of another 10,000 pages of files, it turns out that Pfizer hired at least 600 more people to deal with the spike of adverse reactions that were reported after the vaccine became approved. Although it looks like they might’ve actually hired three times that…
Facts Matter (April 8): VAERS Data Analysis Shows Numerous Health Problems More Likely Due To Vaccines Than Coincidence
Pfizer Hired 600 Employees Due to ‘Large Increase of Adverse Event Reports’: Document
Pfizer hired 600 employees in the months after its COVID-19 vaccine was authorized in the United States due to the “large increase” of reports of side effects linked to the vaccine, according to a document prepared by the company. Pfizer has “taken a multiple actions to help alleviate the large increase of adverse event reports,”…
FDA Clears 4th COVID-19 Shot for All Americans Aged 50 and Above
U.S. drug regulators on March 29 announced they’ve granted emergency authorization for a second booster of the Pfizer and Moderna COVID-19 vaccines The Food and Drug Administration (FDA) is allowing a fourth dose of the jabs to all Americans aged 50 and above. In addition, Americans aged 12 above with weakened immune systems may get…
COVID Vaccine Maker Moderna Flags Japan Ambition With Sumo Sponsorship
TOKYO—Moderna Inc. is sponsoring sumo flags in its first such promotion in Japan, as the COVID-19 vaccine maker seeks to wrestle market share from compatriot Pfizer Inc. The U.S. firm’s introduction to the broader Japanese public was set back after some of its doses last year were found to be contaminated, although it has clawed…
Pfizer Recalling Some Blood Pressure Drug Products With ‘Above Acceptable’ Levels of Cancer-Causing Impurity
Pfizer said on Monday that it is voluntarily recalling some of its blood pressure drug products and two authorized cheaper generic versions of the drug due to elevated levels of a potentially cancer-causing impurity. The pharmaceutical giant said it is recalling six lots of Accuretic (quinapril HCl/hydrochlorothiazide) tablets, one lot of quinapril and hydrochlorothiazide tablets, and four lots of…
‘Global Collaboration’: Victorian Government in Agreement with Pfizer
The Victorian state government has announced an agreement with the biopharmaceutical company Pfizer to increase “global collaboration opportunities with Victorian researchers and industry” on Mar. 18. Victoria’s minister for innovation and medical research, Jaala Pulford said that “this agreement with one of the world’s leading biopharmaceutical companies is a strong endorsement of the strength of…
35 Global Firms to Produce Pfizer’s Oral COVID Drug for Low-Income Countries
The U.N.-backed Medicines Patent Pool (MPP) said Thursday that 35 global firms have agreed to manufacture the generic version of Pfizer’s oral COVID-19 drug, Paxlovid, for distribution in 95 low-and middle-income countries. Paxlovid is a combination of two antiviral drugs–nirmatrelvir, which blocks the virus from replicating, and ritonavir–which slows down nirmatrelvir’s breakdown to help it…
Facts Matter (March 15): New Amendment Introduced to Eliminate Dr. Fauci’s Position To Prevent ‘Health Dictatorship’
According to recent comments made by Dr. Anthony Fauci, it looks like Americans should brace for more and more vaccine doses. This is interesting to note because Fauci’s comments came just a day after the CEO of Pfizer told a news outlet that they are looking to get their fourth vaccine dose through FDA approval. And during…
US Government, Pfizer ‘All Agreed’ to Delay Decision on Company’s COVID-19 Vaccine for Young Children: Bourla
The United States government and Pfizer reached an agreement to delay the U.S. regulatory decision on the company’s COVID-19 vaccine for children as young as 6 months old, Pfizer’s CEO said on March 13. “We all agreed it’s better if we wait for the three doses to come out,” CEO Albert Bourla said on CBS’…
Pfizer CEO: Fourth COVID-19 Vaccine Dose Neccessary
The CEO of Pfizer said Sunday that a fourth dose of the COVID-19 vaccine will be necessary, claiming that it will continue to reduce hospitalizations. “Clearly we are not where we would all like to be, which is [where] COVID is behind us,” CEO Albert Bourla told CBS News. “I think that right now we have…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`